ArticleCureus2025
Purpura Fulminans Secondary to Haemophilus influenzae in an Infant.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpura fulminans (PF) is a hematological emergency that requires timely diagnosis for effective management. In this report, we discuss the case of a five-month-old previously healthy male who presented to the emergency department due to sudden-onset lethargy and rash in the setting of intermittent fevers, emesis, and diarrhea. Shortly after admission, the patient was noted to have rapidly progressive PF and was intubated due to impeding respiratory failure and hemodynamic instability requiring the institution of vasopressors and steroids for catecholamine-resistant, refractory septic shock. He was initially managed with a course of broad-spectrum antimicrobials, including ceftriaxone, doxycycline, and vancomycin, while awaiting the results from his blood and urine cultures. Unfortunately, our patient progressed to multi-organ failure and disseminated intravascular coagulation requiring advanced organ support, including the need for continuous renal replacement therapy. He was transferred to another facility for evaluation and continued management of his necrotic and gangrenous tissues, where he ultimately died after experiencing septic shock in the setting of bacteremia. Although blood and urine cultures were negative, his microbial cell-free DNA sequencing (Karius test) was positive for
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.